drugset / Trial / NCT00406991

Retinal Blood Flow and Microthrombi in Type 1 Diabetes

NCT00406991

Phase 2 Completed 100 enrolled Schepens Eye Research Institute
RandomizedParallel-groupDouble-blindDiagnostic

Summary

The project aims to find mechanisms for the abnormal retinal blood flow that in diabetic patients often precedes any evidence of clinical retinopathy and may contribute to the development of retinopathy. Specifically, the projects tests the hypothesis that reduced retinal blood flow found in young patients with type 1 diabetes reflects increased resistance in the small vessels of the retina caused by the formation of small blood clots, called microthrombi; and that antiplatelet agents normalize the reduced retinal blood flow.

Timeline

Start
2003-06
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg
Subject Clopidogrel Small molecule